1. Home
  2. AIRE vs IMRN Comparison

AIRE vs IMRN Comparison

Compare AIRE & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$1.44

Market Cap

11.5M

Sector

N/A

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$1.10

Market Cap

9.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
IMRN
Founded
2021
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
9.6M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
AIRE
IMRN
Price
$1.44
$1.10
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$1.30
N/A
AVG Volume (30 Days)
59.7K
25.2K
Earning Date
04-28-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
N/A
EPS
N/A
N/A
Revenue
$4,518,498.00
N/A
Revenue This Year
$129.06
N/A
Revenue Next Year
$83.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
376.42
N/A
52 Week Low
$0.16
$0.68
52 Week High
$3.98
$2.38

Technical Indicators

Market Signals
Indicator
AIRE
IMRN
Relative Strength Index (RSI) 43.92 47.43
Support Level $0.29 $1.07
Resistance Level $1.64 $1.24
Average True Range (ATR) 0.15 0.09
MACD 0.03 -0.01
Stochastic Oscillator 46.15 35.02

Price Performance

Historical Comparison
AIRE
IMRN

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: